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1. Prologue
The discovery of the progenitor antibiotics penicillin and 
streptomycin in the 1940s was an event of great signifi cance 
in the history of medicine. It heralded the advent of the 
antibiotics era. Subsequently, several antibiotics of natural 
and synthetic origin became available for clinical use. 
Antibiotic therapy of bacterial (and fungal) infections in 
humans and animals came to be established as standard 
medical practice. There is no gainsaying that the use of 
antibiotics, called ‘magic bullets’ in popular parlance, 
mitigated a lot of suffering and saved millions of lives from 
an inevitable death that would have occurred otherwise, 
not to speak of the big spurt in the pharmaceutical and 
allied industries. On the other hand, two major problems 
have also arisen, raising questions about the continued 
and indiscriminate use of antibiotics. One is the emergence 
of heritable antibiotic resistance in susceptible microbial 
populations, their spread by horizontal gene transfer and 
lack of strategies to contain them (reviewed by Levy and 
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Marshall 2004). Some pathogens have become resistant 
to most of the commonly used antibiotics. The notorious 
‘superbug’ MRSA (methicillin-resistant Staphylococus 
aureus), which is resistant to all the β-lactam antibiotics 
and sensitive only to vancomycin (a glycopeptide antibiotic) 
is a case in point. This limits the choice of treatment for 
MRSA infections to vancomycin. Of late, vancomycin-
resistant MRSA has also emerged, having acquired the 
trait from vancomycin-resistant enterococci by horizontal
gene transfer (see Levy and Marshall 2004). The other 
problem that has emerged due to antibiotic therapy is
the persistence of bacterial infections in which the
pathogens linger in the host for long periods of time in 
spite of prolonged treatment. Some well-known examples 
are tuberculosis, syphilis, typhoid fever (the carrier state), 
gastric ulcer, lung infections in patients with cystic fi brosis 
and many more. In these diseases, the pathogens remain 
stably associated with the host, recalcitrant to therapeutic 
agents and host defence mechanisms. We need to gain a 
deeper understanding of the mechanism(s) of persistence 
in order to develop strategies to tackle problems associated 
with persistence. Some excellent reviews on this subject 
have appeared recently (Levin and Rozen 2006; Lewis 2007, 
2008; Blaser and Kirscher 2007).
2. The persistent state
Bacterial persistence is the capacity of bacteria to
tolerate exposure to lethal concentrations of bactericidal 
antibiotics. This property was fi rst noticed by Bigger 
(1944), soon after penicillin was introduced for clinical use. 
Bigger noticed that treatment of cultures of Staphylococcus 
aureus with high concentrations of penicillin did not kill 
all the cells; a small fraction, of the order of 10–6 or less, 
survived. This fraction regrew after removal of the antibiotic 
and was, surprisingly, as sensitive to penicillin as the 
original population, again leaving behind a tiny fraction 
of survivors. Bigger coined the terms ‘persistence’ and 
‘persisters’ to denote the phenomenon and the survivors 
of antibiotic exposure, respectively. He also suggested that 
persisters are in a state of dormancy, insusceptible to the 
action of penicillin, a view which has remained essentially 
unchanged even after 60-odd years. At that time, the only 
antibiotic known was penicillin whose mechanism of 
action was yet to be understood. In retrospect, Bigger’s 
ingenuity in testing persisters for antibiotic sensitivity upon 
regrowth seems remarkable. In all likelihood, a present-
day microbiologist would have discarded them as being 
spontaneous antibiotic-resistant mutants! Unfortunately, 
the phenomenon of persistence did not attract the serious 
attention of microbiologists till the 1980s, although there 
were sporadic reports on the topic (McCune and Tompsett 
1956; McDermot 1958).
3. Drug indifference versus persistence
Studies on the mode of action of penicillin and its 
descendents (the β-lactam group of antibiotics) as well 
as other antibiotics revealed a close relationship between 
antibiotic sensitivity and growth rate of bacteria (Lee et al 
1944; Trumanen et al 1986; Zeller and Voigt 1987; Aridesi et 
al 2003). In general, non-growing or slow-growing bacteria 
are less sensitive to antibiotics. This property is called 
‘drug indifference’. Drug indifference has been known for 
more than fi fty years and has been demonstrated in vivo 
using experimental animal infection models (for details, 
see Levin and Rozen 2006). Drug indifference is not the 
same as persistence. It is a refl ection of the overall reduced 
sensitivity of dormant/slow-growing microbial populations, 
with no specifi c mechanistic basis. The property is elicited 
by the whole population. Persistence, on the other hand, 
is a special case of drug indifference, restricted to a small 
subpopulation and has a mechanistic basis of origin which is 
not fully understood (see below).
4. Persistent state and biofi lms
The traditional view of bacteria is that they are free-fl oating 
and free-swimming organisms. However, in nature, many 
bacterial species exist in organized structures called 
‘biofi lms’. Biofi lms consist of an exopolysachharide matrix 
in which several bacterial species (bacterial consortia) are 
embedded. They are highly organized, surface-adherent 
structures, found on a variety of biological and non-
biological surfaces. Many clinical infections are ascribed 
to biofi lms. Some examples are dental plaques, gingivitis, 
infections of the middle ear, lung infections in patients 
with cystic fi brosis, etc. Many informative reviews on 
biofi lms are available (Hall-Stoodley et al 2004; Kolter and 
Greenberg 2006; Jayaraman and Wood 2008).
The characteristic property of biofi lm-associated bacteria 
relevant to the present discussion is their recalcitrance to 
eradication by antibiotics (Fux et al 2005; Lewis 2001, 
2005, 2007, 2008). Actually, biofi lm-associated bacteria are 
not antibiotic resistant since the same cells are sensitive in 
the planktonic state. Moreover, Spoering and Lewis (2001) 
and Harrison et al (2005 a, b) showed that biofi lm cells are 
sensitive to fl uoroquinolones (ciprofl oxacin, ofl oxacin, etc.) 
and metal oxyanions such as chromate, arsenate, tellurate, 
etc. which could kill growing as well as non-growing 
cells. Even at high doses of ciprofl oxacin, a fraction of 
cells survives in biofi lms suggesting that they could be 
persisters (Brooun et al 2000). Based on these observations, 
Lewis suggested a model for the insensitivity of biofi lm-
associated cells to elimination by antimicrobials. According 
to his model (outlined in detail in Lewis 2008), treatment 
with ciprofl oxacin eliminates the planktonic cells and the 
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majority of biofi lm-associated cells except the persisters, 
while the persister cells outside the biofi lm matrix are killed 
by the host’s immune mechanisms. Once the antibiotic 
is withdrawn, the persisters inside the biofi lm grow and 
repopulate the niche leading to secondary infection. 
Secondary infection, in turn, generates antibiotic-sensitive 
cells as well as antibiotic-tolerant persisters. The infection is 
perpetuated in this manner in spite of prolonged therapy.
5. Persistence and infectious diseases
Persisters pose formidable diffi culties in the treatment 
of many infectious diseases. This problem has been 
discussed at length by Levin and Rozen (2006) and 
Lewis (2007, 2008) in general terms, and by Gomez and 
McKinney (2004) with special reference to tuberculosis. 
Although not appreciated very much, the problems posed 
by persisters are no less intractable than those posed by 
genetically antibiotic-resistant organisms. For example, 
biofi lm-associated Pseudomonas aeruginosa infections in 
the lungs of patients with cystic fi brosis, a typical persister 
state, are incurable (see Lewis 2007, 2008). Using a 
mathematical model and computer simulation, Wiuff et al 
(2005) showed that persistence (phenotypic tolerance, as 
they called it) could have profound effects on clearing of 
bacteria by antibiotics, and could actually prevent clearing 
resulting in treatment failure. Moreover, antibiotic-tolerant 
persisters pose another confounding problem in that 
they are often shielded from the host’s immune defence 
systems as well; apparently they ‘hide’ in various niches 
such as the central nervous system (Treponema pallidum), 
macrophages or granulomas (Mycobacterium tuberculosis), 
biofi lms (Pseudomonas aeruginosa), stomach (Helicobacter 
pylori), gallbladder (Salmonella typhi), etc. As suggested by 
Levin and Rozen (2006), with the help of a mathematical 
model, a reservoir of such shielded persisters are a potential 
source for the emergence of heritable antibiotic resistance. 
Effective therapy of bacterial infections should aim not 
only at eradicating antibiotic-sensitive pathogens but also 
at eliminating persisters or preventing their emergence. At 
the same time, associated problems such as the development 
of heritable resistance, toxicity, undesirable side-effects, 
costs, etc. should be kept in focus. These issues have been 
exhaustively dealt with in the reviews of Levin and Rozen 
(2006) and Lewis (2007, 2008).
6. Nature and generation of persisters
As pointed out earlier, Bigger’s suggestion that persisters 
are in a state of dormancy, which enables them to tolerate 
antibiotic exposure, has not changed with time. Over 
the years, a large body of evidence has accumulated to 
substantiate the idea. However, there has not been much 
progress in our understanding of how persistence occurs. 
The main reason for this was the diffi culty in obtaining 
persister cells in suffi cient quantity for experimentation, 
since the frequency of their occurrence is extremely small. 
However, a breakthrough occurred in the 1980s with the 
work of Moyed and his group who isolated a high persister 
(hip) mutant of E. coli (Moyed and Bertrand 1983; Moyed 
and Broderick 1986; Black et al 1991). The hip locus maps at 
34.2–34.3 min on the chromosome and consists of two genes 
hip A and hip B. In the best studied hip allele, hip A7, the 
frequency of persisters after ampicillin exposure could reach 
as high as 1% of the population (a 10 000-fold increase over 
the wild-type). The hip genes form an operon, the hip BA 
operon, the expression being B  A (Black et al 1991). We 
will return to hip BA later on. Another high-persister locus 
(hip Q) has been identifi ed in E. coli by Wolfson et al (1990). 
However, hip Q mutants have not been as well studied as hip 
A mutants in terms of physiology and genetics. 
With the availability of the hip mutants of E. coli, it 
became possible to isolate persister cells in suffi cient 
numbers for analysis. Two methods have been developed 
for the isolation of persister cells. The extremely simple 
method developed by Keren et al (2004) is to expose log 
phase cultures of E. coli to ampicillin till lysis (about 3 h) 
and collect the surviving cells (persisters) by centrifugation. 
Another method developed by the same group (Shah et al 
2006) exploits the low transcriptional output in persisters 
due to their dormancy. By inserting a green fl uorescent 
protein (GFP) reporter gene placed under the control of the 
rrnBPI promoter at the att site of the E. coli chromosome 
and sorting out the cells into bright green and dim green 
types, slow-growing subpopulations of cells could be 
isolated. This population showed a 20-fold higher tolerance 
to ofl oxacin than the bright green (normally growing) cells. 
However, this method is time-consuming, expensive and not 
suitable for large-scale preparations. ‘A rapid method for 
isolating large numbers of persisters is yet to be developed,’ 
(Lewis 2007).
Making direct observations on single cells of wild-type, 
hip A7 and hip Q mutants growing in a specially designed 
microfl uidic chamber coupled with mathematical analysis, 
Balaban et al (2004) have identifi ed several features of 
persistence. In the hip A7 mutant the persisters (which 
they call type I persisters) are a subpopulation of non-
growing cells generated at the stationary phase of the 
previous growth cycle and are therefore proportional to the 
inoculum size. These cells take a very long lag (~14 h) to 
exit the stationary phase, compared to ~40 min by normal 
stationary-phase cells. The persisters in the hip Q mutant 
(called type II persisters) are generated during growth. They 
are also slow growers relative to non-persisters, but are not 
as growth arrested as type I persisters. Their proportion in 
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a growing population is dependent on the number of cells 
but independent of the inoculum size. Wild-type cells, on 
the other hand, show a more complex population dynamics 
than the hip mutants. They consist of three subpopulations, 
namely, normal (non-persister) cells, type I persisters carried 
over from the inoculum and type II persisters generated 
during growth. The signifi cance of the work of Balaban et 
al (2004) lies in its beauty and elegance. It provided direct, 
visual evidence for the existence of two classes of cell types 
in cultures of hip A7 and hip Q mutants; one, a fast-growing 
and ampicillin-sensitive class (normal cells) and the other, 
a slow-growing and ampicillin-tolerant class (persisters). 
Apparently, both were present before antibiotic exposure. 
The work also showed that the slow-growing (ampicillin-
tolerant) cells switched to the fast-growing (ampicillin-
sensitive) type. Unfortunately, it is not possible to conduct 
such elegant experiments with wild-type cells since the 
frequency of persisters is ~1000-fold less. Subsequently, 
Kussell et al (2005) developed a theoretical model, using 
which they compared the population dynamics of wild-type 
and hip Q-mutant cells. Their results show that in wild-type 
cells, persistence is optimized to face very rare antibiotic 
challenges (one day or less in 100 years), while in the hip 
Q-mutant, it is optimized to frequent and intense antibiotic 
challenges. The fi tness loss due to reduced growth rate in 
persisters pays off as a risk-reducing strategy. Kussell et al 
(2005) call this an ‘insurance’ strategy!
While mutations in hip A and hip Q increase the 
frequency of persisters, mutations in other genes such 
as glpD (glycerol-3-phosphate dehydrogenase) and plsB 
(glycerol-3-phosphate acyl transferase) reduce persister 
frequency in stationary-phase cultures by mechanisms not 
yet understood (Spoering et al 2006). A suggestion has been 
made that these genes might be required for maintenance of 
the persistent state rather than its generation (Lewis 2007, 
2008). Perhaps pho U may also belong to this list (Li and 
Zhang 2007). Recently, more mutations that reduce persister 
frequency have been identifi ed (Hansen et al 2008; see 
below). The hip A7 mutant shows increased persistence not 
only to β-lactam antibiotics (penicillin, ampicillin, etc.) but 
also to fl uoroquinolones, (ciprofl oxacin), aminoglycosides 
(tobramycin), DNA damaging agents, heat, etc. (see Keren 
et al [2004] for references).
7. Gene expression in persisters
The gene expression profi le of isolated persister cells of the 
hip A7 mutant reported by Keren et al (2004) showed that 
nearly 300 genes were overexpressed in them; many genes 
were also downregulated. Among the overexpressed genes, 
many belong to defi ned functional groups. Genes such as 
recA, umuDC, uvrAB, sulA, etc. belong to the SOS family; 
others such as htrA, htpX, cspH, clpB cbpAB, clpB, etc. 
belong to the heat and cold shock response family; many 
genes (dinJ/yafQ, yefM, relBE, mazEF, etc.) are TA modules 
(see below). Another gene overexpressed in persisters is rmf, 
a gene coding for a translation inhibitor. The transcriptome 
profi le of slow-growing cells isolated by the method of 
Shah et al (2006) is very similar but not identical to that of 
hip A7 persister cells reported by Keren et al (2004). Apart 
from overexpression of TA modules, there was a general 
downregulation of genes involved in energy production and 
non-essential functions such as fl agellar synthesis in wild-
type and hip A7 persisters. This pattern of gene expression 
is consistent with the notion that persisters are in a state of 
dormancy.
8. Toxin–antitoxin modules and persistence
Genomes of prokaryotes and plasmids have some genetic 
elements called TA modules (Gerdes et al 2005). Typically, 
they consist of two genes expressed as an operon. One of the 
genes encodes a stable toxin (which inhibits some important 
cellular functions) and the other an unstable antitoxin which 
neutralizes the toxin and also acts as an autoregulator of 
expression. While they constitute a maintenance function in 
plasmids (Hayes 2003), their role in bacteria is not precisely 
known. They have been suggested to trigger programmed 
cell death (PCD) in response to stress (starvation, antibiotic 
encounter, DNA damage, heat, etc.) (Aizenman et al 1996; 
Sat et al 2001; Hazen et al 2004). On the other hand, some 
workers believe that they do not cause cell death but act as 
inhibitors of macromolecular synthesis leading to reversible 
inhibition of growth (bacteriostasis) (Christensen et al 2001; 
Gerdes 2000). This view is supported by observations that 
the stasis brought about by the toxin could be reversed 
by expression of the cognate antitoxin gene or tmRNA 
(Pedersen et al 2002; Christensen et al 2003).
In their experiments on gene expression in persistent 
cells of E. coli, Keren et al (2004) observed that some well-
characterized TA modules (relBE, mazEF, dinJ/yafQ) were 
among the overexpressed genes. Pursuing this observation 
further, they found that overexpression of plasmid-borne rel 
E, the toxin gene component of the rel BE operon, coding 
for a translation inhibitor (Christensen et al 2001) resulted 
in a 10–10 000-fold increase in persisters in response to 
ofl oxacin (a fl uoroquinolone), cefotaxime (a cephalosporin) 
and tobramycin (an aminoglycoside). In order to see 
whether the hip BA operon could also be a TA module 
they exploited the cold-sensitive phenotype of the hip A7 
mutant as follows. The high persister hipA7 mutant is cold 
sensitive (no growth at 30°C) possibly due to the inability 
of the mutant Hip A protein to complex with the wild-type 
Hip B protein at 30°C. If true, this might lead to the failure 
of neutralization of the Hip A toxin by Hip B antitoxin and 
hence the dominance of the HipA toxin, resulting in growth 
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inhibition at 30°C. In agreement with this hypothesis, the hip 
A7 mutant yielded a lot more persisters at 30°C than 37°C 
(Karen et al 2004). Falla and Chopra (1998) have reported 
earlier that overexpression of hip A increased the production 
of persisters tolerant to β-lactam and fl uoroquinolone 
antibiotics. These observations imply that hip BA could be 
a TA module and suggest a general role for TA modules 
in generating persisters in response to antibiotic and other 
stresses. It is interesting to note that ygi U (which, along 
with ygi T, could be a TA module) is the most overexpressed 
gene in slow-growing cells and causes a dramatic increase in 
tolerance to ofl oxacin, more than hip A7 or rel E (Shah et al 
2006). However, Vazquez-Laslop et al (2006) reported that 
very limited overexpression (causing only minimal inhibition 
of cell growth) of not only hip A and maz F (TA modules) 
but also unrelated (non-TA) genes such as dna J of E. coli 
and pmr C of Salmonella typhimurium resulted in persister 
cells tolerant to ampicillin and ciprofl oxacin. Therefore, it 
seems that expression of many genes besides TA modules 
could lead to the production of dormant persister cells.
9. More on hip A alleles and persister formation
Korch et al (2003) showed that the hip A7 mutant of
E. coli carries two point mutations in hip A – a G22S and a 
D291A. Both the mutations were shown to be necessary for 
its cold-sensitive phenotype while the D291A lesion alone, 
at low levels of expression, was suffi cient for persistence. 
Interestingly, inactivation of the rel A–spo T gene pair, 
involved in the synthesis of the alarmone gunanosine 3′ 5′ 
bispyrophosphate, (p)ppGpp, brought the persister levels of 
the hip A7 mutant to that of the hip A+ wild-type strain. This 
defect could be complemented in trans by the wild-type rel 
A’ gene. Based on these observations, they proposed a model 
of persister formation invoking a causative role for (p)ppGpp 
(see below). Overproduction of ppGpp by induced expression 
of the cloned rel A gene was earlier shown by Rodionov and 
Ishiguro (1995) to result in growth inhibition and ampicillin 
tolerance. However, as pointed out by Korch et al (2003), 
the experiments of Rodionov and Ishiguro used cultures 
in which ppGpp synthesis was induced prior to exposure 
to ampicillin. Therefore, the apparent ‘tolerance’ to the 
antibiotic could be due to populationwide drug indifference 
consequent upon growth inhibition brought about by high 
ppGpp levels rather than persistence, which is restricted to 
a small subpopulation. Korch and Hill (2006) reported in 
a recent publication that overexpression of plasmid-borne, 
wild-type hip A inhibited DNA, RNA and protein synthesis, 
and resulted in growth arrest in a majority (~90%) of the 
population. Cells in which growth was not arrested (colony 
formers post-induction of hip A) emerged as persisters after 
ampicillin exposure. Interestingly, the fraction of persisters 
arising after hip A overexpression in hip A+ cells was 
comparable to that obtained with the hip A7 mutant under 
normal growth conditions. An intriguing observation of 
Korch and Hill (2006) was that overexpression of plasmid-
borne hip A7 caused neither marked growth arrest nor 
inhibition of macromoleular (protein) synthesis. Still, hip 
A7 is a high persister-yielding mutant. Moreover, inhibition 
of protein synthesis by tetracycline or chloramphenicol did 
not increase persister frequency. Therefore, it is diffi cult to 
strictly correlate persister formation with the adverse effects 
of hip A on macromolecular synthesis and growth inhibition 
alone. In addition, the loss of colony-forming ability after 
hip A overexpression was shown to be bacteriostatic 
rather than bactericidal and could be reversed by induced 
expression of the cognate antitoxin gene hip B (Korch and 
Hill 2006). Correia et al (2006) reported that hip A is a 
member of the phosphatidylinositol 3/4 kinase superfamily, 
the fi rst bacterial member to be identifi ed. They showed 
that replacement of the conserved aspartate residues at 309 
(active site) or 322 (Mg2+ binding site) of the Hip A protein 
with glutamine (D309Q and D322Q, respectively) failed 
to arrest growth or yield persisters upon overexpression. 
The Hip A protein has a serine residue at 150 which is 
phosphorylated in about 50% of the molecules in vivo. 
Replacing the serine at 150 with alanine (S150A) had 
similar effects as the other mutants with altered aspartate 
residues at 309 and 322 (see above). However, the target(s) 
of Hip A kinase activity is/are still unknown; other than 
autophosphorylation of serine at 150, kinase activity has 
not been shown with any other substrate. Summing up, the 
recent reports discussed above have shown a close linkage 
between hip A (probably its protein/lipid kinase activity) and 
induction of dormancy and persister formation. Precisely 
how this is effected is still elusive.
The model of persister formation proposed by Keren 
et al (2004; reviewed by Lewis 2007, 2008) suggests that 
toxins such as Hip A, Rel E, etc. inactivate the targets 
of action of antibiotics (ribosomes, cell wall synthetic 
machinery, DNA gyrase/topoisomerase, etc.). When this 
happens, the antibiotics can no longer ‘corrupt’ their 
targets into malfunctioning. In the absence of toxins, the 
antibiotics would corrupt their targets to malfunction and 
lead ultimately to cell death. Therefore, whether or not 
the toxin-inactivated antibiotics bind to the target, the net 
result will be antibiotic tolerance (persistence). (This is 
like keeping a criminal behind bars to prevent him form 
committing crimes!) The model proposed by Korch and Hill 
(2003) is based on their observations that deletion of the 
rel A and spo T genes, responsible for (p)ppGpp synthesis, 
almost abolishes the high-persistence phenotype of the hip 
A7 mutant and this defect could be complemented by the rel 
A’ gene in trans. (The rel A’ gene encodes a truncated from 
of Rel A protein and could synthesise (p)ppGpp without 
ribosomal involvement (Schreiber et al 1991.) According 
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to this model, the primary event in persister formation is 
increase in intracellular levels of (p)ppGpp, which leads to 
dormancy and persister formation. According to Korch and 
Hill (2003), dormancy may not be a critical requirement since 
overexpression of hip A7 does not cause growth inhibition 
but still results in high persister generation (Korch and Hill 
2006). Although a lot more is now known about persisters 
and their origin than earlier, the exact mechanism(s) which 
generate(s) them remains largely unknown. It is possible 
that there could be more than one mechanism of persister 
formation (see below). The two mechanisms proposed for 
persister formation are discussed in detail later.
10. Possible involvement of other loci in persister 
formation
In a recent report, Hansen et al (2008) presented data on 
the screening of an E. coli knockout library comprising 
3985 open reading frames (ORFs) encoding non-essential 
functions for decrease/abolition of persister formation 
using an improvised screening procedure. Their search 
ultimately led to the identifi cation of ten gene knockouts 
which were not affected in either growth rate or minimum 
inhibitory concentration (MIC) for ofl oxacin, but showed 
decreased persister formation. There were: dna J and dna 
K (chaperones), apa H (diadenosine tetraphosphatase), 
sur A (peptidyl-prolyl cis-trans isomerase), fi s and hns 
(global regulators), hnr (response regulator of rpo S), dks 
A (transcriptional regulator of rRNA synthesis), ygf A 
(5-formyl tetrahydrofolate cycloligase) and yig B (fl avin 
mononucleotide [FMN] phosphatase). The preponderance 
of global regulatory genes in this list suggests redundancy in 
the mechanisms of persister formation. Interestingly, none 
of them resulted in total abolition of persister formation, 
but only resulted in a ~10-fold decrease, strengthening the 
idea of operation of redundant pathways and mechanisms in 
the process. They have also discussed in detail the possible 
role(s) of these genes. Due to limitation of space, it is not 
possible to discuss all of them here; the reader is referred to 
the report of Hansen et al (2008) for detailed information. 
Deletion of dna K has been shown earlier to decrease 
persister formation in Staphylococcus aureus exposed to 
oxacillin (Singh et al 2007).
Hansen et al (2008) have emphasized the possible effects 
of knockout mutations in two loci, namely, ygf A and ygi 
B. The mammalian homologue of the former converts the 
stable, 5-formyl tetrahydrofolate into unstable (degradable) 
5,10-methenyl tetrahydrofolate (Anguera et al 2003). They 
suggest that if this be true of E. coli also, ygf A knockouts will 
lead to depletion of the cellular folate pool and ultimately to 
inhibition of the metabolic pathways that require 5-formyl 
tetrahydrofolate as a co-factor. Similarly, knockout of ygi 
B, which is an FMN phosphatase (Kuznetsova et al 2006), 
will result in depletion of the cellular FMN pool. Therefore, 
both the knockouts will result in dormancy, which could be a 
prerequisite for persister formation. Intriguingly, knockouts 
of other FMN-specifi c phosphatase genes are neutral with 
respect to persister formation (Hansen et al 2008). Moderate 
overexpression of cloned ygf A and ygi B resulted in elevated 
persistence in cells exposed to ofl oxacin.
11. Persistence as a stochastic process
The traditional thinking in microbiology has been to 
consider clonal (genetically homogeneous) populations 
of bacteria as phenotypically homogeneous also. To some 
extent, this view was inevitable because the technology 
available in earlier times enabled only studies on bacterial 
populations rather than individual bacterial cells. However, 
in recent times, newer techniques have come into use such 
as fl ow cytometry, observations on single cells growing in 
microfl uidic channels by single-cell time-lapse fl uorescent 
microscopy along with other conventional techniques such 
as mathematical modelling, computer simulations, etc. 
The traditional view of phenotypic homogeneity in clonal 
populations is changing. It is now well established that a lot of 
phenotypic heterogeneity exists in genetically homogeneous 
populations. In other words, a clonal population may have 
two (bistability) or more (multistability) subpopulations 
with distinct phenotypic properties, arising due to ‘noise’ 
in gene expression patterns. Examples of such bistable/
multistable states have been known for a long time and 
new insights are being gained. Some of the well known 
examples are the lysis/lysogeny decision in E. coli infected 
with phage λ; development of ‘competence’ (ability to take 
up extracellular DNA), sporulation, cannibalism, swimming 
and chaining, etc. in B. subtilis; chemotaxis, induction of 
the Lac operon, spontaneous SOS induction, etc. in E. coli, 
and many more. The underlying mechanism of phenotype 
variability has been attributed to ‘noise’ in the level of 
expression of a key regulatory factor. For instance, the 
decision to ‘choose’ either the lytic or the lysogenic mode of 
development in λ phage-infected cells is determined by the 
dominance of Cro versus CI proteins early in the infection 
process with the activity of the CII activator protein being a 
crucial determinant of the decision (Ptashne 2004; Dodd et 
al 2005). Likewise, competence development in B. subtilis 
is governed by the level of the ComK protein (van Sinderen 
et al 1995). Switching to generate alternate phenotypes can 
occur in response to environmental perturbations (responsive 
switching) or spontaneously (stochastic switching). The 
latter equips cells to face environmental perturbations: an 
‘insurance’ against future catastrophe whether it occurs or 
not. Several excellent reviews and reports on phenotypic 
heterogeneity in bacteria have appeared recently (Balaban 
et al 2004; Kussell et al 2005; Kussell and Leibler 2005; 
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Maamer and Dubnau 2005; Kearns and Losick 2005; 
Dubnau and Loscik 2006; Smits et al 2006; Avery 2006; 
Suel et al 2006; Dhar and McKinney 2007). Lewis 
originally suggested that bacterial persistence could involve 
TA modules, and stochastic noise in the TA balance could be 
the switch that triggers the onset of persistence (Lewis et al 
2000, 2005). 
Many of the experiments discussed earlier in this review 
have shown that overexpression of hip A and other TA 
modules results in a high frequency of persisters. Moreover, 
upsetting the possible Hip A–Hip B balance at 30°C elevated 
persister frequency in the hip A7 mutant (Keren et al 2004). 
The experiments of Balaban et al (2004) discussed 
earlier showed two types of persisters in E. coli. Type I 
persisters arise during the stationary phase of growth and 
are carried over during subculturing. Type II persisters, 
on the other hand, arise during growth. Both types 
were shown to be present in cultures before exposure 
to antibiotic stress. Apparently, both are generated by 
stochastic switching. This raises an interesting question. 
Since persisters are dormant, slow-growing/non-growing 
subpopulations, they obviously have a reduced fecundity. 
Why has evolution selected stochastic switching over 
response switching for the generation of persisters? Dhar 
and McKinney (2007) have raised and discussed this 
point in some depth. Under catastrophic situations when 
the very survival of the population is threatened and when 
response switching would be impossible to achieve, having 
an ‘insured’ subpopulation would ensure propagation of the 
genome after the crisis blows over (see also Lewis 2007, 
2008). Using a mathematical model, Kussell and Leibler 
(2005) have suggested that stochastic switching would be 
evolutionarily favoured when environmental perturbations 
are infrequent, while response switching would be favoured 
in rapidly fl uctuating environments. Moreover, as Dhar 
and McKinney (2007) have pointed out, use of E. coli 
strains maintained in the laboratory for long periods of 
time in the absence of environmental perturbations of any 
kind, especially antibiotic stress, would not be expected to 
maintain mechanisms of response switching to antibiotic 
tolerance (persistence). It would be more appropriate to 
use wild strains (as against laboratory-maintained strains) 
and antibiotic-refractory species such as Mycobacterium 
tuberculosis for examining persister mechanisms (Dhar and 
McKinne 2007). 
12. Where do we stand today: an appraisal
From the preceding discussion, it is apparent that much effort 
has gone into the identifi cation of genes responsible for the 
generation of persisters and in delineating the molecular 
mechanism(s) of persistence. From the available data, 
the case for involvement of TA modules in the generation 
of persisters seems strong in spite of some uncertainties. 
Not only are many TA modules overexpressed in isolated 
persisters, but also their effects on macromolecular synthesis 
leading to stasis or death have been well documented. 
Several studies have pointed to hip A as one of the genes 
crucial to persister formation; however, it is not among 
the overexpressed genes in the expression profi le reported 
by Keren et al (2004). Although their report is silent on 
this aspect, it is possible that hip A might not have been 
overexpressed in the early log phase cells used by them for 
isolation of persisters. The characteristic phenotype of hip 
A7 is pronounced only in the stationary phase of growth 
while other TA modules such as rel E are expressed in mid-
log cells also. Even among the 300-odd genes overexpressed 
in persisters, only a few (~2%; which include TA modules, 
SOS genes, heat and cold shock genes, etc.) are implicated 
in persister formation. It is conceivable that the rest of the 
overexpressed genes could be involved in other functions 
such as maintaining the structural integrity of the cells, 
viability, ability to resume growth, housekeeping functions, 
etc. Some of them could also overlap with genes expressed 
in other stress responses such as starvation, DNA damage, 
etc. It is also ironical that hip A as well as other TA modules 
do not fi gure in the screening of Hansen et al (2008). Since 
there are more than ten TA modules in E. coli (Pedersen
et al 2002) it is possible that insertions in hip A or any other 
TA module could have escaped detection by the activity of 
other TA modules. However, it is also known that deletion 
of only hip BA, but not other TA modules, reduces persister 
frequency, an observation that runs counter to the above 
argument. This only shows how little we know of the genes 
responsible for persistence. Moreover, there are many 
inconsistencies between the reports of different workers such 
that data from one are different from another and cannot be 
strictly compared. For instance, in the gene expression 
profi le reported by Keren et al (2004) din J, rel E and maz 
F were among the overexpressed TA modules, whereas in 
the report of Shah et al (2006) the list included din J, yeo 
B and yef M; only din J was common between the two. 
Similarly, ygi U, which was reported by Shah et al (2006) 
as being highly overexpressed, does not fi gure in the list of 
Keren et al (2004). While the latter authors used the hip A7 
mutant for their experiments, the former used a wild-type 
strain. Whether the differences are due to differences in the 
nature of persisters in the two strains, as suggested by Shah 
et al (2006) is a moot question. The downregulated genes 
might be responsible for the generation and maintenance of 
dormancy required for persister formation.
Among the models on the mechanism(s) of origin 
of persistence, the one proposed by Keren et al (2004; 
reviewed by Lewis 2007, 2008) has strong experimental 
support. Several cases in which overexpression of TA 
modules (and a few non-TA genes) resulted in persistence 
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have been reviewed above. All these rely on the (untested) 
hypothesis that the toxins inactivate or inhibit their targets 
(components of cell wall synthesis, replication, translation, 
etc.) and prevent them from corrupting their activities and 
thereby rendering the cells antibiotic tolerant. Korch et 
al (2003) reported a model invoking a causative role for 
the alarmone (p)ppGpp in persistence. To the best of the 
author’s knowledge, this is the only report implicating 
(p)ppGpp in persistence (except that of Rodionov and 
Ishiguro 1995; see below). The hypothesis of Korch and Hill 
that elevated levels of (p)ppGpp pushes the cells into the 
persistent state has not yet been substantiated; nevertheless, 
it is an interesting possibility. However, according to Korch 
et al (2003), antibiotic stress is needed to increase the levels 
of (p)ppGpp. If this were true, one would expect it to be 
not restricted to a subpopulation but occur in all cells, as is 
generally the case in stress responses. Balaban et al (2004) 
have shown that persisters exist in cells before antibiotic 
stress is imposed. Therefore, even if high (p)ppGpp levels 
were to be responsible for the generation of persistence, it 
could be brought about by stochastic switching (see above) 
in a subpopulation, either by increased synthesis or decreased 
degradation or both. The dormancy of persisters has been 
documented very well. While persisters are dormant, all 
dormant cells are not persisters. Something else besides 
dormancy seems necessary. Dormancy requires shutting 
or slowing down of the metabolic processes, especially 
macromolecular synthesis. While this requirement poses no 
problems in hip A+ strains, it does in hip A7 mutants. Korch 
and Hill (2006) have shown that overexpression of hip A+ 
inhibits macromolecular synthesis, but overexpression 
of hip A7 has only marginal effects on the process. This 
paradox has not been resolved satisfactorily although some 
explanations have been offered (Korch and Hill 2006). 
Both the models discussed above have one piece of strong 
experimental support each. The report of Correia et al 
(2006) that mutational alterations at the aspartate residues 
at positions 309 and 322 of the Hip A protein abolished its 
ability to arrest cell growth and afford protection against 
cefotaxime and ofl oxacin exposure strongly supports the 
Karen–Lewis model. On the other hand, the observation 
of Korch et al (2003) that deletion of rel A and spo T 
(based on which they proposed their model) abolished 
persistence in the hip A7 mutant and that the defect could 
be complemented by the rel A’ gene in trans supports the 
(p)ppGpp-mediated persistence model. This strengthens the 
notion that that there may not be a single unique mechanism 
giving rise to persistence. Many, perhaps not mutually 
exclusive, mechanisms might be involved. It is tempting 
to speculate that the two models discussed above might 
be two aspects of the same process and could be combined 
to give a ‘unifi ed’ model of persistence. According to this 
speculation, stochastic increase in (p)ppGpp levels in a 
subpopulation might ‘activate’ toxins (especially Hip A) 
to interact with its/their targets and lead to persistence or, 
alternatively, stochastic increase in toxin levels and binding 
to their respective targets might ‘activate’ rel A–spo T to 
overproduce (p)ppGpp leading to persistence. Intuitively, 
the former seems more appealing and plausible. Many 
experiments could be designed to test the above hypothesis. 
As pointed earlier, the (p)ppGpp-mediated ampicillin 
tolerance reported by Rodionov and Ishiguro (1995) seems 
to be a case of populationwide drug indifference rather 
than persistence, since the whole population seems to be 
protected from lysis by ampicillin. Although multidrug 
tolerance (synonymous with persistence) has been shown 
by Wiuff et al (2005), they have focused more on the 
clinical relevance of the phenomenon than on the molecular 
mechanism(s). Another mechanism of antibiotic (ampicillin) 
tolerance is that proposed by Miller et al (2004) invoking the 
SOS response as the trigger. Levin (2004) has commented 
that this may not be persistence but an additional synergistic 
process producing the same end result, namely, antibiotic 
tolerance. SOS-triggered antibiotic tolerance has not been 
explored further.
Summing up, the identifi cation of genes involved in 
persister formation and the mechanism of persistence are 
still in a nebulous state. We are not anywhere near to arriving 
at a comprehensive and satisfactory picture of how persisters 
arise and how persistence works. Many uncertainties remain. 
Obviously, more efforts are needed to understand and clarify 
the multitude of problems and issues.
13. Persistence as a form of social behaviour in 
bacteria
The phenomenon of bacterial persistence has recently 
attracted the attention of evolutionary biologists and 
sociobiologists. Contrary to the earlier traditional belief 
that bacteria are simple and independent creatures, living 
and minding ‘their own business’ of life, reproduction and 
death, it is now known that they indulge in an astonishing 
array of complex social behaviours. Some examples are: 
quorum sensing, biofi lm formation, persistence (a recent 
addition), resource utilization, bacteriocin synthesis, etc. 
(reviewed by West et al 2006, 2007a). Gardner et al (2007) 
have developed a theoretical model to investigate the social 
aspects of bacterial persistence. Without going into the 
subtleties of modelling, their work is summarized below 
from a non-specialist’s perspective. As pointed out in the 
earlier sections of this review, persistence is conceived 
as an insurance policy to guarantee population survival 
when faced with catastrophic situations such as antibiotic 
exposure. Evolutionary biologists reject the idea of traits 
being favoured because they benefi t populations (West 
et al 2007 b). No doubt persistence primarily benefi ts the 
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persister because it enables survival during adversity (selfi sh 
benefi t). However, because of their reduced growth rate 
(dormancy), they make critical resources available to non-
persisters and facilitate their growth (social benefi t), more 
so if the latter happen to be relatives (kin selection). Thus, 
persistence confers cooperative, mutual benefi ts on the self 
and others. The model of Gardner et al (2007) also predicts 
that at high population densities (late log/stationary phase) 
when resource competition would be intense, the fraction 
of cells that becomes persisters would be high. This is what 
has been found experimentally and also in clinical settings 
by several workers. Many parallels can be drawn between 
persistence and another, well-studied microbial social 
behaviour, namely, biofi lms. For one, both involve reversible 
lifestyle switches. In the case of persistence, it is a switch 
from active growth to slow growth or dormancy. In the case 
of biofi lms, it is a switch from a nomadic (planktonic) to a 
sedentary lifestyle (biofi lm). The mechanisms involved or 
presumed to be involved are also similar. The transition from 
a nomadic to a sedentary state in biofi lms has been shown to 
be caused by an increase in the levels of a compound called
(3′-5′) cyclic dimeric guanosine monophosphate (c-di-GMP; 
see Kolter and Greenberg 2006 for references). This is
similar to the increase in the levels of toxins such as Hip A
over those of antitoxins such as Hip B in the case of
persistence. Persisters are believed to confer cooperative 
growth benefi ts on their kin by virtue of their dormancy. 
A parallel to this in biofi lms is the exit of some cells from 
the matrix to reduce competition inside and thereby help 
the biofi lm cells to grow. Such parallels can be drawn 
between many social behaviours of bacteria, but it is beyond 
the scope of this review to attempt such an exercise. The 
excellent review by West et al (2007 b) gives a detailed 
account of many social behaviours of bacteria and could 
be consulted for more information. Studies on phenomena 
such as persistence, quorum sensing, etc. in several species 
of bacteria have led to the emergence of an interdisciplinary 
offshoot of Microbiology which has been christened 
‘Sociomicrobiology’ by Parsek and Greenberg (2005). 
Hopefully, the nascent discipline of Sociomicrobiology will 
make great strides in future. 
14. Epilogue
In contrast to the enormous efforts to understand 
mechanisms of persister generation and action, the 
properties of persisters, especially their mutagenic potential, 
seem to have received very little attention. Many reports 
have suggested that persisters are a potential source for the 
emergence of heritable antibiotic resistance. However, this 
idea does not seem to have been put to experimental test. 
Persisters are not as dormant as spores but are slow or very 
slow growers. (Refer to type I and type II persiters described 
by Balaban et al 2004.) A vast body of literature is available 
on the mutagenic potential of cells in the slow-growing state 
or stationary phase. I have earlier suggested that ‘leaky’ 
growth of E .coli could be mutagenic (Jayaraman 2000). It 
is tempting to speculate that mechanisms of stationary phase 
mutagenesis may also operate in persisters. The mutagenic 
potential of persisters may not be restricted only to the 
emergence of antibiotic resistance but may be generalized. In 
other words, the ‘insurance’ that persisters enjoy may cover 
many risks. Evolutionarily also, it makes sense and it is more 
advantageous to be prepared to face threats of different kinds 
than just one. The overexpression of SOS genes like rec A, 
umu C, umu D etc. in persister cells (Keren et al 2004) and 
SOS induction by ampicillin (Miller et al 2004) lend some 
credence to the above notions. Although persisters are a 
clinical menace, they may have some evolutionary value in 
the generation of spontaneous genetic variability.
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to exploit inhibition of persistence as a potential therapeutic 
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